- Single-dose prefilled syringe: 30 mcg/0.5 mL.
- Powder for injection (single use vial): 30 mcg.
- Autoinjector: 30 mcg/0.5 ml
- Combining interferon beta-1a with zidovudine (Retrovir) or hydroxyurea (Hydrea) may increase the risk of bone marrow suppression with reduced blood cell counts.
PREGNANCY AND BREASTFEEDING SAFETY:
- Use of interferon beta-1a has not been adequately evaluated in pregnant women. Due to the lack of conclusive safety data, interferon beta-1a should be used in pregnancy only if the potential benefit justifies the potential risk to the fetus.
- It is not known if interferon beta-1a is excreted in breast milk. As many drugs enter breast milk and can potentially cause harm to the nursing infant, interferon beta-1a should be used cautiously in nursing mothers
- Preferably interferon beta-1a should be stored refrigerated between 2 C to 8 C (36 F to 46 F).
- If needed, interferon beta-1a powder can be stored at 25 C (77 F) for up to 30 days if a refrigerator is not available. It must be used within 6 hours if refrigerated at 2 C to 8 C (36 F to 46 F) once the powder is diluted with solution
- The autoinjector and prefilled syringe may be stored at 25 C (77 F) or lower temperatures for 7 days if a refrigerator is not available. Once the product is removed from the refrigerator, it must not be stored above 25 C (77 F).
Quick GuideMultiple Sclerosis Pictures Slideshow: Causes, Symptoms and Treatment
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Need help identifying pills and medications?
Use the pill identifier tool on RxList.